Familial dilated cardiomyopathy: cardiac abnormalities are common in asymptomatic relatives and may represent early disease
MK Baig,
JH Goldman,
AL Caforio,
AS Coonar,
PJ Keeling,
and
WJ McKenna
Department of Cardiological Sciences, St. George's Hospital Medical School, London, England, United Kingdom. baigk@sghms.ac.uk
OBJECTIVES: This study sought to determine whether early disease is identifiable in asymptomatic relatives of patients with dilated cardiomyopathy (DCM) by means of noninvasive cardiologic assessment. BACKGROUND: DCM is diagnosed on the basis of advanced heart failure, where cardiac dilation and impaired contractility are recognized in the absence of a recognized etiology (World Health Organization criteria). However, initial clinical presentation may be with severe complications: thromboembolism, arrhythmia or sudden death. DCM has recently been recognized to be familial, with autosomal dominant inheritance in many cases. Familial disease is present in 9% to 20% of patients with DCM, and the ability to identify early disease in such people may improve patient management and aid in the understanding of pathogenesis. METHOD: We prospectively assessed 408 asymptomatic relatives (mean [+/-SD] age 35 +/- 15 years, 193 men) of 110 consecutive patients with DCM by means of history and physical examination, two-dimensional echocardiography, 12-lead and signal-averaged electrocardiography and metabolic exercise testing. We hypothesized that signs of lesser cardiac dysfunction in such relatives might indicate early disease. RESULTS: Twenty-nine percent of relatives had abnormal results on the echocardiogram. Twenty percent (n = 45) had left ventricular enlargement (LVE), defined as LV end-diastolic diameter (LVEDD) > or = 112% predicted; 6% (n = 13) had depressed fractional shortening (dFS), defined as FS < or = 25%; and 3% (n = 7) had frank DCM, defined as LV dilation, impaired contractile performance and LVEDD > or = 112% plus FS < or = 25%. Other abnormalities of cardiac function were identified in relatives with LVE or dFS: A greater number with LVE had an abnormal metabolic exercise test result than normal relatives (9% vs. 1%, p < 0.05). Relatives with LVE and abnormal maximal oxygen consumption (VO2max) (defined as VO2max < 80% predicted) had a lower absolute VO2max than normal relatives (30 +/- 8 vs. 43 +/- 9 ml/min per kg, p = 0.01). The QRS duration (at the 25-Hz filter) on the signal-averaged electrocardiogram was prolonged in relatives with LVE (103 +/- 13 ms) and dFS (102 +/- 12 ms) compared with that of normal relatives (97 +/- 12 ms, p < 0.05). Over a mean 39-month follow-up period, 12 relatives with LVE (27%) and none with dFS developed symptomatic DCM (p < 0.0001). One relative with LVE died suddenly, and another underwent heart transplantation. CONCLUSIONS: Nearly one-third of asymptomatic relatives (29%) have echocardiographic abnormalities, and 27% of such relatives progress to development of overt DCM. Early identification of such people would permit appropriate intervention that might influence the serious complications and mortality of this disease.
This article has been cited by other articles:

|
 |

|
 |
 
K. M. Brauch, M. L. Karst, K. J. Herron, M. de Andrade, P. A. Pellikka, R. J. Rodeheffer, V. V. Michels, and T. M. Olson
Mutations in ribonucleic Acid binding protein gene cause familial dilated cardiomyopathy.
J. Am. Coll. Cardiol.,
September 1, 2009;
54(10):
930 - 941.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
O. M. Hess, W. McKenna, and H.-P. Schultheiss
CHAPTER 18 Myocardial Disease
ESC Textbook of Cardiovascular Medicine,
January 1, 2009;
2(1):
med-9780199566990-chapter - med-9780199566990-chapter.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Jerosch-Herold, D. C. Sheridan, J. D. Kushner, D. Nauman, D. Burgess, D. Dutton, R. Alharethi, D. Li, and R. E. Hershberger
Cardiac magnetic resonance imaging of myocardial contrast uptake and blood flow in patients affected with idiopathic or familial dilated cardiomyopathy
Am J Physiol Heart Circ Physiol,
September 1, 2008;
295(3):
H1234 - H1242.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. H. Robin, P. B. Tabereaux, R. Benza, and B. R. Korf
Genetic Testing in Cardiovascular Disease
J. Am. Coll. Cardiol.,
August 21, 2007;
50(8):
727 - 737.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. E. F. Daubeney, A. W. Nugent, P. Chondros, J. B. Carlin, S. D. Colan, M. Cheung, A. M. Davis, C.W. Chow, R. G. Weintraub, and on behalf of the National Australian Childhood Car
Clinical Features and Outcomes of Childhood Dilated Cardiomyopathy: Results From a National Population-Based Study
Circulation,
December 12, 2006;
114(24):
2671 - 2678.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Richard, E. Villard, P. Charron, and R. Isnard
The Genetic Bases of Cardiomyopathies
J. Am. Coll. Cardiol.,
October 27, 2006;
48(9_Suppl_A):
A79 - A89.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. S. Lee, M. J. Pencina, E. J. Benjamin, T. J. Wang, D. Levy, C. J. O'Donnell, B.-H. Nam, M. G. Larson, R. B. D'Agostino, and R. S. Vasan
Association of parental heart failure with risk of heart failure in offspring.
N. Engl. J. Med.,
July 13, 2006;
355(2):
138 - 147.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. T. Ellinor, S. Sasse-Klaassen, S. Probst, B. Gerull, J. T. Shin, A. Toeppel, A. Heuser, B. Michely, D. M. Yoerger, B.-S. Song, et al.
A Novel Locus for Dilated Cardiomyopathy, Diffuse Myocardial Fibrosis, and Sudden Death on Chromosome 10q25-26
J. Am. Coll. Cardiol.,
July 4, 2006;
48(1):
106 - 111.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y Matsumura, P M Elliott, N G Mahon, M S Virdee, Y Doi, and W J McKenna
Familial dilated cardiomyopathy: assessment of left ventricular systolic and diastolic function using Doppler tissue imaging in asymptomatic relatives with left ventricular enlargement.
Heart,
March 1, 2006;
92(3):
405 - 406.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Mirza, S. Marston, R. Willott, C. Ashley, J. Mogensen, W. McKenna, P. Robinson, C. Redwood, and H. Watkins
Dilated Cardiomyopathy Mutations in Three Thin Filament Regulatory Proteins Result in a Common Functional Phenotype
J. Biol. Chem.,
August 5, 2005;
280(31):
28498 - 28506.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. G. Mahon, R. T. Murphy, C. A. MacRae, A. L.P. Caforio, P. M. Elliott, and W. J. McKenna
Echocardiographic Evaluation in Asymptomatic Relatives of Patients with Dilated Cardiomyopathy Reveals Preclinical Disease
Ann Intern Med,
July 19, 2005;
143(2):
108 - 115.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. L. Burkett and R. E. Hershberger
Clinical and genetic issues in familial dilated cardiomyopathy
J. Am. Coll. Cardiol.,
April 5, 2005;
45(7):
969 - 981.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. M. Olson, V. V. Michels, J. D. Ballew, S. P. Reyna, M. L. Karst, K. J. Herron, S. C. Horton, R. J. Rodeheffer, and J. L. Anderson
Sodium Channel Mutations and Susceptibility to Heart Failure and Atrial Fibrillation
JAMA,
January 26, 2005;
293(4):
447 - 454.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. T. Murphy, R. Thaman, J. G. Blanes, D. Ward, E. Sevdalis, E. Papra, A. Kiotsekolglou, M. T. Tome, D. Pellerin, W. J. McKenna, et al.
Natural history and familial characteristics of isolated left ventricular non-compaction
Eur. Heart J.,
January 2, 2005;
26(2):
187 - 192.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Repetto, A. Serio, M. Pasotti, A. Fontana, A. Bertoletti, L. Scelsi, G. Magrini, L. Monti, C. Campana, S. Ghio, et al.
Rescreening of "healthy" relatives of patients with dilated cardiomyopathy identifies subgroups at risk of developing the disease
Eur. Heart J. Suppl.,
November 1, 2004;
6(suppl_F):
F54 - F60.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. D. Cheitlin, W. F. Armstrong, G. P. Aurigemma, G. A. Beller, F. Z. Bierman, J. L. Davis, P. S. Douglas, D. P. Faxon, L. D. Gillam, T. R. Kimball, et al.
ACC/AHA/ASE 2003 guideline update for the clinical application of echocardiography: summary article: a report of the American college of cardiology/American heart association task force on practice guidelines (ACC/AHA/ASE committee to update the 1997 guidelines for the clinical application of echocardiography)
J. Am. Coll. Cardiol.,
September 3, 2003;
42(5):
954 - 970.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. D. Cheitlin, W. F. Armstrong, G. P. Aurigemma, G. A. Beller, F. Z. Bierman, J. L. Davis, P. S. Douglas, D. P. Faxon, L. D. Gillam, T. R. Kimball, et al.
ACC/AHA/ASE 2003 Guideline Update for the Clinical Application of Echocardiography: Summary Article: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASE Committee to Update the 1997 Guidelines for the Clinical Application of Echocardiography)
Circulation,
September 2, 2003;
108(9):
1146 - 1162.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Not, E. Faleschini, A. Tommasini, A. Repetto, M. Pasotti, V. Baldas, A. Spano, D. Sblattero, R. Marzari, C. Campana, et al.
Celiac disease in patients with sporadic and inherited cardiomyopathies and in their relatives
Eur. Heart J.,
August 1, 2003;
24(15):
1455 - 1461.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. J. Wang, D. Levy, E. J. Benjamin, and R. S. Vasan
The Epidemiology of "Asymptomatic" Left Ventricular Systolic Dysfunction: Implications for Screening
Ann Intern Med,
June 3, 2003;
138(11):
907 - 916.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. R. G. Taylor, P. R. Fain, G. Sinagra, M. L. Robinson, A. D. Robertson, E. Carniel, A. Di Lenarda, T. J. Bohlmeyer, D. A. Ferguson, G. L. Brodsky, et al.
Natural history of dilated cardiomyopathy due to lamin A/C gene mutations
J. Am. Coll. Cardiol.,
March 5, 2003;
41(5):
771 - 780.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. L. P. Caforio, N. G. Mahon, and W. J. McKenna
Reply
J. Am. Coll. Cardiol.,
January 1, 2003;
41(1):
169 - 170.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. S. Hamid, M. Norman, A. Quraishi, S. Firoozi, R. Thaman, J. R. Gimeno, B. Sachdev, E. Rowland, P. M. Elliott, and W. J. McKenna
Prospective evaluation of relatives for familial arrhythmogenic right ventricular cardiomyopathy/dysplasia reveals a need to broaden diagnostic criteria
J. Am. Coll. Cardiol.,
October 16, 2002;
40(8):
1445 - 1450.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J Grzybowski, Z T Bilinska, J Janas, E Michalak, and W Ruzyllo
Plasma concentrations of N-terminal atrial natriuretic peptide are raised in asymptomatic relatives of dilated cardiomyopathy patients with left ventricular enlargement
Heart,
August 1, 2002;
88(2):
191 - 192.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. L.P. Caforio, N. J. Mahon, F. Tona, and W. J. McKenna
Circulating cardiac autoantibodies in dilated cardiomyopathy and myocarditis: pathogenetic and clinical significance
Eur J Heart Fail,
August 1, 2002;
4(4):
411 - 417.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. A. Crispell, E. L. Hanson, K. Coates, W. Toy, and R. E. Hershberger
Periodic rescreening is indicated for family members at risk of developing familial dilated cardiomyopathy
J. Am. Coll. Cardiol.,
May 1, 2002;
39(9):
1503 - 1507.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. G. Mahon, A. E. Hedman, M. Padula, Y. Gang, I. Savelieva, J. E.P. Waktare, M. M. Malik, H. V. Huikuri, and W. J. McKenna
Fractal correlation properties of R-R interval dynamics in asymptomatic relatives of patients with dilated cardiomyopathy
Eur J Heart Fail,
March 1, 2002;
4(2):
151 - 158.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. G. Mahon, B. P. Madden, A. L. P. Caforio, P. M. Elliott, A. J. Haven, B. E. Keogh, M. J. Davies, and W. J. McKenna
Immunohistologic evidence of myocardial disease in apparently healthy relatives of patients with dilated cardiomyopathy
J. Am. Coll. Cardiol.,
February 6, 2002;
39(3):
455 - 462.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N G Mahon, B Zal, G Arno, P Risley, J Pinto-Basto, W J McKenna, M J Davies, and C Baboonian
Absence of viral nucleic acids in early and late dilated cardiomyopathy
Heart,
December 1, 2001;
86(6):
687 - 692.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Gavazzi, A. Repetto, L. Scelsi, C. Inserra, M.L. Laudisa, C. Campana, C. Specchia, B. Dal Bello, M. Diegoli, L. Tavazzi, et al.
Evidence-based diagnosis of familial non-X-linked dilated cardiomyopathy. Prevalence, inheritance and characteristics
Eur. Heart J.,
January 1, 2001;
22(1):
73 - 81.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
A. M. Feldman and D. McNamara
Myocarditis
N. Engl. J. Med.,
November 9, 2000;
343(19):
1388 - 1398.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. M. Katz
Cytoskeletal Abnormalities in the Failing Heart : Out on a LIM?
Circulation,
June 13, 2000;
101(23):
2672 - 2673.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N G Mahon, S Sharma, P M Elliott, M K Baig, M W Norman, S Barbeyto, and W J McKenna
Abnormal cardiopulmonary exercise variables in asymptomatic relatives of patients with dilated cardiomyopathy who have left ventricular enlargement
Heart,
May 1, 2000;
83(5):
511 - 517.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
G. S. Francis
Heart failure
J. Am. Coll. Cardiol.,
April 1, 2000;
35(5_Suppl_B):
6B - 9B.
[PDF]
|
 |
|

|
 |

|
 |
 
L. Mangin, P. Charron, F. Tesson, A. Mallet, O. Dubourg, M. Desnos, A. Benaische, C. Gayet, P. Gibelin, J.-M. Davy, et al.
Familial dilated cardiomyopathy: clinical features in French families
Eur J Heart Fail,
December 17, 1999;
1(4):
353 - 361.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. A. Crispell, A. Wray, H. Ni, D. J. Nauman, and R. E. Hershberger
Clinical profiles of four large pedigrees with familial dilated cardiomyopathy: Preliminary recommendations for clinical practice
J. Am. Coll. Cardiol.,
September 1, 1999;
34(3):
837 - 847.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Mestroni, C. Rocco, D. Gregori, G. Sinagra, A. Di Lenarda, S. Miocic, M. Vatta, B. Pinamonti, F. Muntoni, A. L. P. Caforio, et al.
Familial dilated cardiomyopathy: Evidence for genetic and phenotypic heterogeneity
J. Am. Coll. Cardiol.,
July 1, 1999;
34(1):
181 - 190.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Komajda, P. Charron, and F. Tesson
Genetic aspects of heart failure
Eur J Heart Fail,
June 1, 1999;
1(2):
121 - 126.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Catherwood, W. D. Fitzpatrick, M. L. Greenberg, P. T. Holzberger, D. J. Malenka, B. R. Gerling, and J. D. Birkmeyer
Cost-Effectiveness of Cardioversion and Antiarrhythmic Therapy in Nonvalvular Atrial Fibrillation
Ann Intern Med,
April 20, 1999;
130(8):
625 - 636.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. S. Francis
Heart failure
J. Am. Coll. Cardiol.,
February 1, 1999;
33(2):
291 - 294.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Early Cardiomyopathy in Asymptomatic Relatives?
Journal Watch Cardiology,
January 26, 1998;
1998(126):
7 - 7.
[Full Text]
|
 |
|

|
 |

|
 |
 
P. Meneton, M. Bloch-Faure, A. A. Hagege, H. Ruetten, W. Huang, S. Bergaya, D. Ceiler, D. Gehring, I. Martins, G. Salmon, et al.
Cardiovascular abnormalities with normal blood pressure in tissue kallikrein-deficient mice
PNAS,
February 27, 2001;
98(5):
2634 - 2639.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|